Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,770 | 1,263 | 10,926 | 11,590 | 4,460 |
| Other current assets | 0 | 0 | 0 | 290 | 340 |
| TOTAL | $8,873 | $1,392 | $11,060 | $11,880 | $4,800 |
| Non-Current Assets | |||||
| PPE Net | 44 | 59 | 33 | 20 | 20 |
| Other Non-Current Assets | 15 | 15 | 15 | 10 | 100 |
| TOTAL | $59 | $74 | $48 | $30 | $120 |
| Total Assets | $8,932 | $1,466 | $11,108 | $11,920 | $4,930 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,299 | 4,654 | 6,373 | 1,080 | 210 |
| Accrued Expenses | 3,149 | 1,930 | 687 | 220 | 7 |
| Other current liabilities | 10,487 | N/A | N/A | 0 | 0 |
| TOTAL | $16,968 | $6,617 | $7,059 | $1,310 | $210 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33 | 33 | N/A | N/A | N/A |
| TOTAL | $400 | $433 | $N/A | $N/A | $N/A |
| Total Liabilities | $17,368 | $7,051 | $7,059 | $1,310 | $210 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -76,072 | -59,693 | -43,242 | -23,680 | -15,390 |
| Other shareholders' equity | 18,460 | 13,904 | 9,919 | -10 | 0 |
| TOTAL | $-8,436 | $-5,585 | $4,048 | $10,600 | $4,720 |
| Total Liabilities And Equity | $8,932 | $1,466 | $11,108 | $11,910 | $4,930 |